Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05253053
What this trial is testing

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCholangiocarcinomaBiliary Tract Cancer+8 more
TransThera Sciences (Nanjing), Inc. 84
Not applicableEnrolling By InvitationNCT06756581
What this trial is testing

Tolerability of Baked Dairy Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein Trigger

Who this might be right for
Eosinophilic Esophagitis (EoE)
Shaare Zedek Medical Center 20
Early research (Phase 1)Study completedNCT01316237
What this trial is testing

A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 90
Early research (Phase 1)Ended earlyNCT03245619
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Investigation of GSK3335065 Intravenous (IV) Infusion in Healthy Adults

Who this might be right for
Pancreatitis, Acute Necrotizing
GlaxoSmithKline 18
Testing effectiveness (Phase 2)WithdrawnNCT03768531
What this trial is testing

Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer

Who this might be right for
Resectable Biliary Tract Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Ended earlyNCT03361228
What this trial is testing

Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 5
Testing effectiveness (Phase 2)Study completedNCT00377182
What this trial is testing

Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 107
Testing effectiveness (Phase 2)Study completedNCT03672188
What this trial is testing

Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Vir Biotechnology, Inc. 82
Not applicableStudy completedNCT05097924
What this trial is testing

Gastrointestinal Tolerability of a Partially Hydrolyzed Ready-to-feed Infant Formula in Healthy Newborns

Who this might be right for
Infant Nutritional Physiological PhenomenaInfant Formula
Société des Produits Nestlé (SPN) 150
Large-scale testing (Phase 3)Study completedNCT00686920
What this trial is testing

Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Bausch Health Americas, Inc. 322
Testing effectiveness (Phase 2)Study completedNCT01318369
What this trial is testing

Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain

Who this might be right for
CannabinoidTetrahydrocannabinolChronic Pancreatitis+1 more
Radboud University Medical Center 24
Early research (Phase 1)Study completedNCT03175497
What this trial is testing

Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Taizhou EOC Pharma Co., Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT01849562
What this trial is testing

Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants

Who this might be right for
Hepatitis C, Chronic
Alexion Pharmaceuticals, Inc. 30
Large-scale testing (Phase 3)Study completedNCT00440297
What this trial is testing

Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)

Who this might be right for
Hepatitis B Virus Infection
Merck Sharp & Dohme LLC 277
Early research (Phase 1)Study completedNCT06365580
What this trial is testing

Dose Escalation Study of Kylo-0603 in Healthy Subjects

Who this might be right for
Nonalcoholic Steatohepatitis
Kylonova (Xiamen) Biopharma co., LTD. 132
Testing effectiveness (Phase 2)Study completedNCT03664960
What this trial is testing

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

Who this might be right for
Eosinophilic GastritisEosinophilic GastroenteritisEosinophilic Duodenitis
Allakos Inc. 58
Early research (Phase 1)Study completedNCT02508467
What this trial is testing

Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Blueprint Medicines Corporation 146
Not applicableWithdrawnNCT02523911
What this trial is testing

Efficacy and Tolerability of Suprep With and Without Simethicone for Routine Colonoscopy for Colorectal Cancer Screening

Who this might be right for
Colorectal Cancer
MercyOne Des Moines Medical Center
Early research (Phase 1)Study completedNCT00753987
What this trial is testing

Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
The Hospital for Sick Children 13
Early research (Phase 1)Study completedNCT02662712
What this trial is testing

Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)

Who this might be right for
HealthyHepatitis, Chronic
Janssen Sciences Ireland UC 87
Next Page